EXPRESSION AND REGULATION OF VACCINIA VIRUS LATE GENES
EXPRESSION AND REGULATION OF VACCINIA VIRUS LATE GENES
批准号:
3131336
负责人:
DENNIS E. HRUBY
金额:
$8.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-12-01 至 1986-11-30
关键词:
cell free system endonuclease gel electrophoresis gene expression genetic manipulation genetic markers genetic regulation genetic transcription genetic translation molecular cloning nucleic acid sequence plasmids temperature sensitive mutant vaccinia virus virus DNA virus RNA virus genetics virus replication
中文摘要
为简单起见,痘苗病毒(VV)基因通常被归类为早期
或较晚的类,取决于它们的表达式是否独立于
依赖于病毒DNA的合成。人们对此知之甚少
控制早期和晚期基因表达切换的机制
VV复制周期中的模式。最近,相当数量的
已经获得了关于结构、核苷酸序列和
一些典型的VV早期遗传基因座的调控。此信息
为后续VV早期基因的鉴定提供依据
监管信号和识别它们的因素。然而到目前为止,
类似的分析还没有对VV晚期基因进行。它是朝着
这一问题是本提案中概述的实验所针对的。
一些VV晚期基因的基因组位置将由两个决定
方法:研究方法。首先,将利用DNA介导的标记救援技术来
绘制温度敏感型或抗药性VV突变体的位置图
在体内表现出有缺陷的晚期表型。第二,VV晚期mRNA
将在无细胞蛋白质合成系统和晚期基因中翻译
根据其酶活性鉴定的产品(病毒粒子
酶)或多肽结构(例如,VP62或VP11)。这些是无细胞的
然后,分析可以与杂交抑制或杂交选择相结合
程序,以映射这些功能。曾经的代表VV迟到了
基因已经定位,最新的重组DNA和分子
生物学技术将被用于研究细胞的结构
转录单位,它们是如何表达和调控的
感染,以及编码多肽的性质和活性。什么时候
与已有的关于VV的信息进行比较和对比
早期基因,这些结果应该会提供一些机制的洞察力
VV用什么来实现其复合体的有序表达
受感染细胞内的发育程序。
英文摘要
For simplicity, vaccinia virus (VV) genes are routinely grouped into early
or late classes depending on whether their expression is independent of, or
dependent on, viral DNA synthesis. Very little is known concerning the
mechanisms which govern the switch between early and late gene expression
modes during the VV replicative cycle. Recently a considerable amount of
data has been obtained concerning the structure, nucleotide sequence, and
regulation of some "typical" early VV genetic loci. This information
should provide the basis for the subsequent identification of VV early gene
regulatory signals and the factors which recognize them. To date however,
similar analyses have not been carried on the VV late genes. It is towards
this problem that the experiments outlined in this proposal are directed.
The genomic location of a number of VV late genes will be determined by two
methods. First, DNA-mediated marker rescue techniques will be employed to
map the positions of temperature-sensitive or drug-resistant VV mutants
which exhibit a defective late phenotype in vivo. Second, VV late mRNA
will be translated in cell-free protein synthesizing systems and late gene
products identified on the basis of their enzymatic activities (virion
enzymes) or polypeptide structure (e.g., VP62, or VP11). These cell-free
assays can then be coupled with hybrid-arrest or hybrid-selection
procedures in order to map these functions. Once representative VV late
genes have been located, state-of-the-art recombinant DNA and molecular
biology techniques will be used to study the structure of the
transcriptional units, how they are expressed and regulated during
infection, and the nature and activity of the encoded polypeptides. When
compared and contrasted to the information already available concerning VV
early genes, these results should provide some insight into the mechanisms
which VV employs to achieve the ordered expression of it's complex
developmental program within the infected cell.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antiviral therapeutics for flavivirus infections
-
批准号:8461110
-
项目类别:
-
资助金额:$115.21万
-
财政年份:2011
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral therapeutics for flavivirus infections
-
批准号:8076148
-
项目类别:
-
资助金额:$144.28万
-
财政年份:2011
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral therapeutics for flavivirus infections
-
批准号:8655139
-
项目类别:
-
资助金额:$124.6万
-
财政年份:2011
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral therapeutics for flavivirus infections
-
批准号:8836475
-
项目类别:
-
资助金额:$119.24万
-
财政年份:2011
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral therapeutics for flavivirus infections
-
批准号:8262150
-
项目类别:
-
资助金额:$126.0万
-
财政年份:2011
-
负责人:DENNIS E. HRUBY
-
依托单位:
Novel small molecule inhibitors of dengue replication
-
批准号:7609216
-
项目类别:
-
资助金额:$40.45万
-
财政年份:2008
-
负责人:DENNIS E. HRUBY
-
依托单位:
Novel small molecule inhibitors of dengue replication
-
批准号:7676164
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2008
-
负责人:DENNIS E. HRUBY
-
依托单位:
Enhancing the immune response to antigens delivered by the bacterial vector, Stre
-
批准号:7273398
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2007
-
负责人:DENNIS E. HRUBY
-
依托单位:
Enhancing the immune response to antigens delivered by the bacterial vector, Stre
-
批准号:7492158
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2007
-
负责人:DENNIS E. HRUBY
-
依托单位:
Bacterial Commensal Vector Delivery/Smallpox Vaccine
-
批准号:7051706
-
项目类别:
-
资助金额:$49.14万
-
财政年份:2006
-
负责人:DENNIS E. HRUBY
-
依托单位:
DEVELOPMENT OF THERAPEUTIC AGENT FOR SELECTED VIRAL DISAESES
-
批准号:7543547
-
项目类别:
-
资助金额:$834.81万
-
财政年份:2006
-
负责人:DENNIS E. HRUBY
-
依托单位:--
Pox Proteomics
-
批准号:6913018
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2005
-
负责人:DENNIS E. HRUBY
-
依托单位:
Pox Proteomics
-
批准号:7087069
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2005
-
负责人:DENNIS E. HRUBY
-
依托单位:
Variola Virus G1L:An Antiviral Drug Target
-
批准号:6903595
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2004
-
负责人:DENNIS E. HRUBY
-
依托单位:
Variola Virus G1L:An Antiviral Drug Target
-
批准号:6747514
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2004
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral Drugs for Category A Arenavirus
-
批准号:6831392
-
项目类别:
-
资助金额:$209.25万
-
财政年份:2003
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral Drugs Against Hemorrhagic Fever Viruses
-
批准号:6916895
-
项目类别:
-
资助金额:$49.58万
-
财政年份:2003
-
负责人:DENNIS E. HRUBY
-
依托单位:
Small Molecule Inhibitors of Smallpox Virus Replication
-
批准号:6916897
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2003
-
负责人:DENNIS E. HRUBY
-
依托单位:
Antiviral Drugs for Category A Arenavirus
-
批准号:6937696
-
项目类别:
-
资助金额:$321.47万
-
财政年份:2003
-
负责人:DENNIS E. HRUBY
-
依托单位:
Small Molecule Inhibitors of Smallpox Virus Replication
-
批准号:6831540
-
项目类别:
-
资助金额:$217.8万
-
财政年份:2003
-
负责人:DENNIS E. HRUBY
-
依托单位:
海外基金